Skip to content

13F-HR filed by Redmile Group, LLC

Redmile Group, LLC filed this 13F-HR for the quarter ended 2013-09-30, filed 2013-11-14, with 50 holding rows worth $663,992,000.

Accession
0001536520-13-000008
Filed
2013-11-14
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q3 2013

A holdings report, 50 entries on the cover page, a total value of $663,992,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $663,992,000 with VALUE read as thousands by filing date, 13F file number 028-12776. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
ACTAVIS INC00507K103COM271,500$39,096,000thousands by filing date
Amgen Inc.031162100COM345,700$38,698,000thousands by filing date
ST JUDE MED INC790849103COM658,000$35,295,000thousands by filing date
Gilead Sciences,Inc.375558103COM529,800$33,293,000thousands by filing date
CUBIST PHARMACEUTICALS INC229678107COM452,600$28,763,000thousands by filing date
CLOVIS ONCOLOGY INC189464100COM471,345$28,648,000thousands by filing date
REGENERON PHARMACEUTICALS COM75886F107Stock80,400$25,155,000thousands by filing date
TENET HEALTHCARE CORP COM NEW88033G407Stock591,000$24,343,000thousands by filing date
CATAMARAN CORP148887102COM508,100$23,347,000thousands by filing date
ARIAD PHARMACEUTICALS INC04033A100COM1,264,009$23,258,000thousands by filing date
ARRAY BIOPHARMA INC COM04269X105Stock3,669,593$22,825,000thousands by filing date
INSULET CORP COM45784P101Stock599,000$21,708,000thousands by filing date
BROOKDALE SR LIVING INC112463104COM757,800$19,930,000thousands by filing date
PUMA BIOTECHNOLOGY INC74587V107COMMON STOCK340,165$18,253,000thousands by filing date
HCA Healthcare Inc40412C101COM414,400$17,716,000thousands by filing date
NUVASIVE INC670704105COM693,392$16,981,000thousands by filing date
CELGENE CORP151020104COM98,600$15,177,000thousands by filing date
ZOETIS INC CL A98978V103Stock465,900$14,499,000thousands by filing date
CHIMERIX INC COM16934W106Stock653,705$14,368,000thousands by filing date
CERUS CORP157085101COM2,052,400$13,772,000thousands by filing date
HEARTWARE INTL INC422368100COM185,125$13,553,000thousands by filing date
Merck & Co.,Inc.58933Y105COM282,500$13,450,000thousands by filing datecall
GLOBUS MED INC CL A379577208Stock736,100$12,852,000thousands by filing date
CAPITAL SENIOR LIVING CORP140475104COM597,300$12,633,000thousands by filing date
ASTRAZENECA PLC SPONSORED ADR046353108ADR236,100$12,261,000thousands by filing date
ARTHROCARE CORP043136100COM342,759$12,195,000thousands by filing date
TORNIER NVN87237108COMMON STOCK-FO568,100$10,981,000thousands by filing date
KYTHERA BIOPHARMACEUTICALS I501570105COM228,218$10,430,000thousands by filing date
PACIFIC BIOSCIENCES CALIF INC COM69404D108Stock1,574,379$8,706,000thousands by filing date
HEALTHWAYS INC422245100COM462,913$8,569,000thousands by filing date
NANOSTRING TECHNOLOGIES INC63009R109COM754,132$8,295,000thousands by filing date
Vertex Pharmaceuticals Incorporated92532F100COM108,262$8,208,000thousands by filing date
ACCURAY INC DEL004397105COM1,073,799$7,935,000thousands by filing date
VCA ANTECH INC918194101COM288,000$7,908,000thousands by filing date
BIOSPECIFICS TECHNOLOGIES090931106COM326,652$6,360,000thousands by filing date
AMICUS THERAPEUTICS INC03152W109COM2,473,787$5,739,000thousands by filing date
SUNSHINE HEART INC86782u106COM470,900$5,453,000thousands by filing date
INTREXON CORP46122T102COM203,600$4,823,000thousands by filing date
VOCERA COMMUNICATIONS INC92857F107COMMON STOCK245,400$4,564,000thousands by filing date
AMARIN CORP PLC023111206SPONS ADR NEW649,700$4,106,000thousands by filing date
ARRAY BIOPHARMA INC04269XAA3NOTE 3.000% 6/03,000,000$3,444,000thousands by filing dateprincipal
GW PHARMACEUTICALS PLC36197T103ADS165,020$2,861,000thousands by filing date
AGIOS PHARMACEUTICALS INC00847X104COM53,100$1,485,000thousands by filing date
RECEPTOS, INC.756207106COMMON STOCK20,800$540,000thousands by filing date
VERASTEM INC92337C104COM31,000$386,000thousands by filing date
MARKET VECTORS PHARM ETF T57060U217ETF6,500$311,000thousands by filing date
REPROS THERAPEUTICS INC76028H209COM10,500$281,000thousands by filing date
ALLERGAN INC018490102COM2,627$238,000thousands by filing date
PERRIGO CO PLC F714290103COM1,700$210,000thousands by filing date
Merck & Co.,Inc.58933Y105COM1,900$90,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001536520-13-000008this filing2013-11-14acceptance time not in the bulk data set